Mr. Deitsch, Chief Executive
Officer of Nutra Pharma Corp. (nutrapharma.com),
served as the President of NDA Consulting
Inc., a biotechnology research group
that provided consulting services to
the pharmaceutical industry. NDA Consulting
specialized in the research of peptides
derived from Cone Snail venom, Cobra
venom and Gila Monster venom. Mr. Deitsch
holds both a B.S. in Chemistry and an
M.S. in Biochemistry from Florida Atlantic
University and has conducted research
for the Duke University Medical School
Comprehensive Cancer Center. Mr. Deitsch
is an adjunct professor and teaches
several courses for Florida Atlantic
University's College of Business and
Continuing Education Department.
Copyright 2007, IK Enterprises
LLC. All Rights Reserved.